PRODUCT FAMILY

Kovanaze

Product Description
St. Renatus has received FDA approval for KOVANAZE (tetracaine HCl and oxymetazoline HCl) nasal spray. This is the first product that allows for dental anesthesia to be administered through a nasal spray without using a needle. KOVANAZE is intended for use in dentistry as a topical anesthetic, delivered in the nasal cavity to achieve pulpal (tooth nerve) anesthesia for the restorative treatment of teeth. Like traditional dental injections, this product delivers a local dental anesthetic but without the needle. KOVANAZE is indicated for regional anesthesia when performing a restorative procedure on teeth Nos. 4 to 13 and A to J in adults and children who weigh 40 kg or more.

Customer Reviews

Rating Breakdown(0.0 average)
Write a Review

QUESTIONS & ANSWERS

Kovanaze
ST. Renatus, LLC
Request Info

Promotions